The Cooper Companies (COO)
(Delayed Data from NSDQ)
$94.69 USD
+2.70 (2.94%)
Updated May 9, 2024 04:00 PM ET
After-Market: $94.72 +0.03 (0.03%) 7:58 PM ET
3-Hold of 5 3
C Value C Growth D Momentum C VGM
The Cooper Companies (COO) Price Targets
Average Price Target | Highest Price Target | Lowest Price Target | Upside to Average Price Target |
---|---|---|---|
$111.75 | $125.00 | $95.00 | 21.48% |
Price Target
Based on short-term price targets offered by 12 analysts, the average price target for The Cooper Companies comes to $111.75. The forecasts range from a low of $95.00 to a high of $125.00. The average price target represents an increase of 21.48% from the last closing price of $91.99.
Analyst Price Targets (12)
Broker Rating
The Cooper Companies currently has an average brokerage recommendation (ABR) of 1.67 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by 15 brokerage firms. The current ABR compares to an ABR of 1.67 a month ago based on 15 recommendations.
Of the 15 recommendations deriving the current ABR, 10 are Strong Buy, representing 66.67% of all recommendations. A month ago, Strong Buy represented 66.67%.
Broker Rating Breakdown
Brokerage Recommendations
Today | 1 Week Ago | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
---|---|---|---|---|---|
Strong Buy | 10 | 10 | 10 | 9 | 8 |
Buy | 0 | 0 | 0 | 0 | 0 |
Hold | 5 | 5 | 5 | 5 | 6 |
Sell | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 |
ABR | 1.67 | 1.67 | 1.67 | 1.71 | 1.86 |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Analyst Upgrades/Downgrades
Date | Brokerage Firm | Analyst | Previous | Current |
---|---|---|---|---|
3/1/2024 | William Blair | Margaret Kaczor | Strong Buy | Strong Buy |
3/1/2024 | Robert W. Baird & Co. | Jeffrey D Johnson | Strong Buy | Strong Buy |
3/1/2024 | Mizuho SecuritiesUSA | Anthony Petrone | Strong Buy | Strong Buy |
3/1/2024 | Piper Sandler | Jason Bednar | Strong Buy | Strong Buy |
2/6/2024 | KeyBanc Capital Markets | Brett Fishbin | Hold | Hold |
1/15/2024 | Needham & Company | David Saxon | Hold | Hold |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Average Brokerage Rating
Current ABR | 1.67 |
ABR (Last week) | 1.67 |
# of Recs in ABR | 15 |
Average Target Price | $111.75 |
LT Growth Rate | 11.30% |
Industry | Medical - Dental Supplies |
Industry Rank by ABR | 146 of 252 |
Current Quarter EPS Est: | 0.83 |